|
Name: Methyldihydromorphine
Type: Opioid
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Methyldihydromorphine, a derivative of morphine, was developed in the early 20th century. It is used for its potent analgesic effects and has been studied for its role in pain management and opioid research.
|
|
V. Legal Information
Methyldihydromorphine is an opioid with significant abuse potential. It is controlled under Schedule I in the United States and similarly regulated worldwide to manage its misuse and protect public health. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Methyldihydromorphine is a synthetic opioid with analgesic effects. It causes sedation, respiratory depression, and constricted pupils. Short-term use is effective for pain management, but long-term use can lead to addiction, tolerance, and severe health issues. Overdose risks include fatal respiratory depression. Safe use involves strict dosing and medical supervision. Recent research focuses on its efficacy and safety profile compared to other opioids.  |
|
VII. Psychological Effects
Methyldihydromorphine, an opioid, provides euphoria and pain relief. Immediate effects include significant mood elevation and cognitive impairment. Long-term use can lead to dependence, tolerance, and withdrawal symptoms. Chronic use is associated with mood disorders, cognitive decline, and high overdose risk. Recent studies emphasize its potent effects and associated psychological risks.
 |
|
VIII. Culture
Methyldihydromorphine is a potent opioid, classifying it as a downer. Short-term use provides significant pain relief, while long-term use can lead to dependence, tolerance, and severe health issues. Overdose risks include severe respiratory depression and potential fatal outcomes. Safe dosages are not well-established, with use typically controlled in medical settings. Recent research highlights its high potency and risks of misuse. Physical effects include drowsiness, constricted pupils, and respiratory depression.
 |